Drugstore chain Rite Aid Corporation (NYSE: RAD) reported a narrower loss from continuing operations in the fourth quarter as it delivered the third consecutive quarter of same-store pharmacy sales and prescription count growth. The bottom line exceeded analysts’ expectations while the top line missed consensus estimates.
Retail Pharmacy Segment revenues were flat compared to the prior year period, while revenue in the Pharmacy Services Segment rose 1.2% on an increase in Medicare Part D membership.
Investors believed the shake-up of the top management, layoff, and reverse stock split will bring the stock above the $1 ground-level.
The company's results in graphical format can be found at https://news.alphastreet.com/rite-aid-q4-2019-earnings-results-rad-stock/
Retail Pharmacy Segment revenues were flat compared to the prior year period, while revenue in the Pharmacy Services Segment rose 1.2% on an increase in Medicare Part D membership.
Investors believed the shake-up of the top management, layoff, and reverse stock split will bring the stock above the $1 ground-level.
The company's results in graphical format can be found at https://news.alphastreet.com/rite-aid-q4-2019-earnings-results-rad-stock/